Prevention of Diabetes in the NOD Mouse by a Th1 Clone Specific for a hsp60 Peptide
- 31 March 2000
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 14 (2) , 133-142
- https://doi.org/10.1006/jaut.1999.0352
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI 25151)
This publication has 45 references indexed in Scilit:
- Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in β CellsScience, 1999
- Islet T Cells Secreting IFN-γ in NOD Mouse Diabetes: Arrest by p277 Peptide TreatmentJournal of Autoimmunity, 1998
- Humoral Mechanisms in T cell Vaccination: Induction and Functional Characterization of Anti-lymphocytic AutoantibodiesJournal of Autoimmunity, 1997
- Peripheral T cell Clones from NOD Mice Specific for GAD65 Peptides: Lack of Islet Responsiveness or DiabetogenicityJournal of Autoimmunity, 1996
- Establishment and Characterization of RAG‐2 Deficient Non‐Obese Diabetic MiceScandinavian Journal of Immunology, 1996
- NOD Mouse Diabetes: The Ubiquitous Mouse Hsp60 is a β-Cell Target Antigen of Autoimmune T CellsJournal of Autoimmunity, 1996
- Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD miceEuropean Journal of Immunology, 1995
- PREVENTION OF OVERT DIABETES AND INSULITIS BY INTRATHYMIC INJECTION OF SYNGENEIC ISLETS IN NEWBORN NONOBESE DIABETIC (NOD) MICETransplantation, 1993
- Differential effect of transforming growth factor β on the synthesis of Th1‐ and Th2‐like lymphokines by human T lymphocytesEuropean Journal of Immunology, 1992
- Correlation of T cell receptor V beta gene family with MHC restriction.The Journal of Experimental Medicine, 1987